HEALTH● LOWJul 28 · Jul 28, 2026, 11:29 AM
Hong Kong drives trials for breast cancer, eye treatments across Greater Bay Area
South China Morning Post
Two US-developed treatments for breast cancer and a degenerative eye disease will undergo large-scale clinical trials in the Greater Bay Area in a collaboration involving Hong Kong, Shenzhen and a pharmaceutical start-up founded by a former lawmaker. The agreement was formalised on Tuesday when Health Hope Pharma founder Dr Dennis Lam Shun-chiu signed a memorandum of understanding with the Greater Bay Area International Clinical Trial Institute (GBAICTI) and its Shenzhen counterpart, Greater Bay...
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH25m agoRussia’s HIV epidemic is worsening despite official claims to the contrary. Here’s what the numbers really show.Meduza [en]HEALTH3h agoEdwards Lifesciences says PASCAL beats medical therapy for tricuspid repairSeeking Alpha TechHEALTH3h agoFitness program cut transplant waitlist death risk by half, study findsThe HillHEALTH4h agoUS dairy worker dies from bird flu as outbreak rages in cattleThe Telegraph